Aspira director reports share transfer and warrants

Aspira Women's Health director Jeffrey K. Cohen reported changes in his holdings.

Rhea-AI Filing Summary

Aspira Women's Health director Jeffrey K. Cohen reported changes in his holdings. The main event was an "other" transaction coded J on September 17, 2025, where 11,112 shares of common stock at $0.45 per share were acquired as payment from another party in settlement of another property.

After this, Cohen directly held 386,018 common shares and indirectly held 71,010 shares through his spouse. He also held warrants to buy 450,318 common shares at $0.35 per share expiring on March 5, 2031, and warrants to buy 41,667 shares at $0.75 per share expiring on September 17, 2030.

Insider Trade Summary

Other: 11,112 shares

Other 4 txns

Insider cohen Jeffrey k

Role Director

Type	Security	Shares	Price	Value
holding	Warrant (Right to Buy)	--	--	--
holding	Warrant (Right to Buy)	--	--	--
holding	Common Stock	--	--	--
Other	Common Stock	11,112	$0.45	$5K

Holdings After Transaction: Common Stock — 386,018 shares (Direct); Warrant (Right to Buy) — 491,985 contracts (Direct); Common Stock — 71,010 shares (Indirect, By Spouse)

Footnotes (1)

1. F1. The shares were acquired as payment to Dr. Cohen from another party in settlement of another property.

Key Figures

Restructuring shares: 11,112 shares at $0.45 Direct common shares: 386,018 shares Indirect common shares: 71,010 shares +2 more

5 metrics

Restructuring shares 11,112 shares at $0.45 J-code other transaction on September 17, 2025

Direct common shares 386,018 shares Common Stock holdings following transaction

Indirect common shares 71,010 shares Indirect ownership by spouse

Warrant position at $0.35 450,318 underlying shares Exercise price $0.35, expires March 5, 2031

Warrant position at $0.75 41,667 underlying shares Exercise price $0.75, expires September 17, 2030

Key Terms

Warrant (Right to Buy), indirect ownership, transaction code J, exercise price, +1 more

5 terms

Warrant (Right to Buy) financial

"security_title: "Warrant (Right to Buy)" with underlying common stock"

indirect ownership financial

"direct_or_indirect: "I" and nature_of_ownership: "By Spouse""

transaction code J financial

"transaction_code: "J" described as other acquisition or disposition"

exercise price financial

"conversion_or_exercise_price fields of $0.3500 and $0.7500"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2031-03-05 and 2030-09-17 for warrants"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Jeffrey K. Cohen report for Aspira Women's Health (AWHL)?

Jeffrey K. Cohen reported an "other" transaction coded J involving 11,112 common shares at $0.45 per share. The filing notes these shares were acquired as payment from another party in settlement of another property, not an open-market trade.

How many Aspira Women's Health (AWHL) common shares does Jeffrey K. Cohen hold after this filing?

After the reported transaction, Jeffrey K. Cohen directly holds 386,018 common shares of Aspira Women’s Health. He also has indirect ownership of 71,010 additional shares held by his spouse, giving a combined reported position across direct and indirect holdings.

What warrants does Jeffrey K. Cohen hold in Aspira Women's Health (AWHL)?

Cohen holds warrants to buy 450,318 common shares at an exercise price of $0.35, expiring March 5, 2031. He also holds warrants to buy 41,667 common shares at $0.75, expiring September 17, 2030, all reported as direct holdings.

Was the Aspira Women's Health (AWHL) insider transaction a market buy or sell?

The transaction was coded J, described as another acquisition or disposition, not a standard market buy or sell. The footnote explains the 11,112 shares were received as payment from another party in settlement of another property.

How many shares were involved in the restructuring-type transaction for AWHL?

The restructuring-type transaction coded J involved 11,112 common shares at $0.45 per share. According to the filing, these shares were acquired as payment in settlement of another property, reflecting a non-market form of consideration.

What indirect ownership in Aspira Women's Health (AWHL) does Jeffrey K. Cohen report?

Cohen reports indirect ownership of 71,010 common shares held by his spouse. This indirect interest is separate from his 386,018 directly held common shares and is explicitly labeled as "By Spouse" in the ownership details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/29/2026 - 04:07 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

cohen Jeffrey k

(Last) (First) (Middle)

C/O ASPIRA WOMEN'S HEALTH INC

12117 BEE CAVES RD, BLDG 3-100

(Street)

AUSTIN TEXAS 78738

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Aspira Women's Health Inc. [ AWHL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/19/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/17/2025		J(1)		11,112	A	$0.45	386,018	D
Common Stock								71,010	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant (Right to Buy)	$0.75							09/17/2025	09/17/2030	Common Stock, par value $0.001	41,667		41,667	D
Warrant (Right to Buy)	$0.35							09/12/2025	03/05/2031	Common Stock, par value $0.001	450,318		450,318	D

Explanation of Responses:

1. The shares were acquired as payment to Dr. Cohen from another party in settlement of another property.

	/s/ Jeffrey Cohen	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)